CDCA2 Promotes HCC Cells Development via AKT–mTOR Pathway

BACKGROUND: Hepatocellular carcinoma (HCC) is a highly aggressive and solid malignancy with a poor prognosis. Cell division cycle associated 2 (CDCA2) is highly expressed in HCC and is considered to be closely related to the prognosis of patients with HCC. In this research, we aimed to investigate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Kai, Fan, Tingting, Shi, Zhongxing, Jiang, Huijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800082/
https://www.ncbi.nlm.nih.gov/pubmed/36588796
http://dx.doi.org/10.1155/2022/9912254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800082/
https://www.ncbi.nlm.nih.gov/pubmed/36588796
http://dx.doi.org/10.1155/2022/9912254

Ejemplares similares